Enfermedades hepáticas víricas, genéticas e inmuno-mediadas
Publicaciones destacadas
-
Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries
Razavi, HA; Buti, M; Terrault, NA; Zeuzem, S; Yurdaydin, C;(...)Villalobos-Salcedo, JM; Voeller, AS; Yang, H; Yu, ML; Zuckerman, E.Referencia:Journal Of Hepatology 2023.
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predni(so)lone administration
Díaz-González, A; Hernández-Guerra, M; Pérez-Medrano, I; Sapena, V; Riveiro-Barciela, M;(...)López, C; Alvarez-Navascúes, C; García-Retortillo, M; Crespo, J; Londoño, MC.Referencia:Hepatology 2023.
-
Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS
Pallett, LJ; Swadling, L; Diniz, M; Maini, AA; Schwabenland, M;(...)Gilroy, DW; Dorner, M; Bengsch, B; Schurich, A; Maini, MK.Referencia:Nature 2023.
-
Non-invasive tests for clinically significant portal hypertension after HCV cure
Semmler, G; Lens, S; Meyer, EL; Baiges, A; Alvardo-Tapias, E;(...)Hernández-Gea, V; Reiberger, T; Bosch, J; Pagán, JCG; Mandorfer, M.Referencia:Journal Of Hepatology 2022.
-
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Sanduzzi-Zamparelli, M; Mariño, Z; Lens, S; Sapena, V; Iserte, G;(...)Forner, A; Torres, F; Bruix, J; Forns, X; Reig, M.Referencia:Journal Of Hepatology 2022.
-
Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study)
Hirode, G; Choi, HSJ; Chen, CH; Su, TH; Seto, WK;(...)Kao, JH; Cornberg, M; Hansen, BE; Jeng, WJ; Janssen, HLA.Referencia:Gastroenterology 2022.
-
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis
Taubert, R; Engel, B; Diestelhorst, J; Hupa-Breier, KL; Behrendt, P;(...)Maasoumy, B; Witte, T; Wedemeyer, H; Manns, MP; Jaeckel, E.Referencia:Hepatology 2022.
-
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
García-López, M; Lens, S; Pallett, LJ; Testoni, B; Rodríguez-Tajes, S;(...)Koutsoudakis, G; Zoulim, F; Maini, MK; Forns, X; Pérez-del-Pulgar, S.Referencia:Journal Of Hepatology 2021.
-
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Lens, S; Baiges, A; Alvarado-Tapias, E; LLop, E; Martinez, J;(...)Hernández-Gea, V; Bosch, J; Villanueva, C; García-Pagán, JC; Forns, X.Referencia:Journal Of Hepatology 2020.
-
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions in the near future
Rodríguez-Tajes, S; Pocurull, A; Castillo, J; Casanova, G; Vega, L;(...)Mariño, Z; Londoño, MC; Forner, A; Torres, F; Forns, X.Referencia:Journal Of Hepatology 2020.
